“Chez nous, le cirque!” clown doctors at Barga hospital with Kedrion Biopharma
The company engaged in a social responsibility initiative at the San Francesco hospital
Kedrion Biopharma strengthens its position on the US market
Granted exclusive rights to commercialize a lifesaving drug in the US
A brand new location for KEDPlasma donors in the very center of Fürth
Plasma collected is turned into life-saving therapies to serve patients in Germany and worldwide
KEDPlasma acquires two plasma centers from ImmunoTek LLC in the US
The acquisition is part of a five-year growth plan of supplying highest-quality plasma to Kedrion Biopharma
Hemophilia A. SIPPET study selected by the American Society of Hematology
Presented at the ASH Congress in Orlando, it was chosen from amongst approximately three thousand studies
Emoked among the best digital projects of 2014
Software designed by Kedrion nominated at the About Pharma Digital Awards
In Arezzo Kedrion reaffirms partnership with Italian Blood System
Quality and safety of blood plasma derivates at center stage in a session of the Risk Management Forum 2015
Kedrion among the key players of Farmindustria’s roadshow in Siena
The Lucca-based company presented as one of the innovative pharmaceutical companies in Tuscany
“Vita” technical college in Siena opens registrations for its first course
The course will be held in Florence over the next two years, and it will train biomedical devices manufacturing technicians
Kedrion supports Fondazione Paracelso’s activities in Afghanistan
Kedrion confirms its commitment to broaden access to hemophilia treatments in developing Countries